Skip to content
Atlas Mark

The Zimbabwean Government Declines ‘Lopsided’ American Health Aid Agreement Due to Information Concerns

Health funding illustration
The offered American funding was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has turned down a significant American health deal valued at $367m (£272m) spanning five years over the United States' insistence on sensitive biological samples.

This move came to light after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the deal was "lopsided".

A government spokesperson has since explained that the US was requesting biological samples for scientific study and profit while was unwilling to guarantee the resulting advantages from future medical innovations.

"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for more talks to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.

Wider Implications

This rejection follows a comparable situation in Kenya, where a high court blocked a similar deal with the US after concerns were filed about the safety of Kenyans' health data.

Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

The agency had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to boost transparency and accountability.

Based on reports, 16 African countries have so far signed these new health pacts, representing over $18.3bn of fresh investment.

Details of the Rejected Deal

The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this cooperation might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via American-funded programmes," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, with no corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"In essence, our country would supply the basic resources for scientific discovery without any assurance that the end products would be accessible to our population if a future pandemic arise."

National Interest and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures previously set up through the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.

"This framework is designed to ensure that when a nation contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.

"We encourage further dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that respects the sovereignty and dignity of both nations."

Medical Community Response

Medical experts expressed it understood the government's concerns, but urged that talks need to persist considering much of the nation's HIV programmes relied on external financing.

"Where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.

The halted deal underscores the complex debate between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.

ST
Written by

Sharon Tucker

A seasoned traveler and cultural anthropologist documenting unique global experiences and sustainable travel practices.

Atlas Mark

Type to search articles.